检索

Renal denervation with a resistant arterial hypertension: the results of a five-year follow-up

Glybochko P., Svetankova A., Rodionov A., Maltseva A., Sulimov V., Fomin V.

(Rus)

卷 85, 编号 12 (2013)

Role of the endothelin receptor antagonist bosentan in the treatment of patients with pulmonary hypertension

Tsareva N.

卷 91, 编号 9 (2019)

Endothelial dysfunction in patients with controlled and uncontrolled arterial hypertension

Podzolkov V., Safronova T., Natkina D.

(Rus)

卷 91, 编号 2 (2019)

Phenotype of obesity and gastroesophageal reflux disease in the context of comorbidity in patients with cardiovascular diseases

Maev I., Yurenev G., Mironova E., Yureneva-Thorzhevskaya T.

(Rus)

Evidence base for specific pulmonary vasodilators in adults with congenital heart disease

Shmalts A., Gorbachevsky S.

(Rus)

卷 92, 编号 9 (2020)

The achievements of the modern specific therapy of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: focus on the stimulator of soluble guanylate cyclase riociguat

Gratsianskaya S., Valieva Z., Martynyuk T.

(Rus)

卷 95, 编号 4 (2023)

Applying of magnetic resonance tomography for assessment of cardiac remodeling and risk stratification in patients with pulmonary arterial hypertension

Shariya A., Martynyuk T., Shariya M., Ustyuzhanin D.

(Rus)

Advantages and limitations of initial combination therapy in pulmonary arterial hypertension patients in Russia

Shmalts A., Gorbachevsky S.

(Rus)

卷 97, 编号 3 (2025): Пульмонология

Historical milestones in the study of pulmonary hypertension

Osokina A., Rodnenkov O., Martynyuk T.

(Rus)

New horizons for the use of the second generation of endothelin receptor antagonist macitentan in patients with pulmonary hypertension

Martynyuk T., Nakonechnikov S., Chazova I.

(Rus)

卷 91, 编号 12 (2019)

A systematic review as a method of gathering scientific evidence into clinical guidelines: CHEST-2019 guideline for the therapy pulmonary arterial hypertension in adults

Shmalts A., Gorbachevsky S.

(Rus)

卷 90, 编号 3 (2018)

Combination therapy is a new standard for treatment of pulmonary arterial hypertension

Avdeev S., Tsareva N., Gaisin I.

(Rus)

卷 90, 编号 3 (2018)

Pulse wave velocity and other indicators of arterial stiffness in hypertension comorbidity and chronic obstructive pulmonary disease

Aksenova T., Gorbunov V., Tsarenok S.

(Rus)

Vascular remodeling with violations of intracardiac hemodynamics in patients older age category, combined with the clinical-cluster, neurocognitive and biomarker heterogeneity in multifocal atherosclerosis

Khasanov A., Bakirov B., Davletshi R., Novikova L., Kudlay D.

(Rus)

卷 92, 编号 10 (2020)

Dynamic changes of renin-angiotensin-aldosterone system parameters after surgery of primary hyperparathyroidism

Dobreva E., Bibik E., Eremkina A., Ajnetdinova A., Nikankina L., Malysheva N., Mokrysheva N.

(Rus)

卷 92, 编号 1 (2020)

Assessment of the clinical efficacy of telemonitoring and distant counseling in patients with uncontrolled hypertension

Ionov M., Zhukova O., Zvartau N., Kurapeev D., Yudina Y., Konradi A.

(Rus)

卷 90, 编号 12 (2018)

Interrelation of erectile dysfunction with obesity in patients with arterial hypertension

Alekseeva T., Shariya M., Gamidov S., Elfimova E., Starostin I., Litvin A., Chazova I.

(Rus)

Pharmacotherapy of resistant arterial hypertension

Shepeleva N., Rodionov A., Fomin V.

(Rus)

卷 95, 编号 9 (2023)

Sartans in the treatment of arterial hypertension: focus on telmisartan and azilsartan. A review

Zakiev V., Kotovskaya Y., Tkacheva O.

(Rus)

The clinical case of successful combined treatment of refractory arterial hypertension. Case report

Solntseva T., Denisova A., Sivakova O., Danilov N., Pevzner D., Chazova I.

(Rus)

卷 93, 编号 1 (2021)

Blood pressure telemonitoring and remote counseling in uncontrolled hypertension

Ionov M., Zhukova O., Zvartau N., Konradi A.

(Rus)

卷 92, 编号 1 (2020)

The epidemiological situation as a factor determining the strategy for reducing mortality in the Russian Federation

Boytsov S., Shalnova S., Deev A.

(Rus)

卷 90, 编号 1 (2018)

Stress in the family - association with prevalence of cardiovascular diseases in men of the open city population

Akimova E., Akimov M., Gakova E., Kayumova M., Gafarov V., Kuznetsov V.

(Rus)

卷 86, 编号 9 (2014)

Practical aspects of treatment in patients with chronic cerebral ischemia and hypertension in general somatic practice

Lebedeva M.

卷 83, 编号 4 (2011)

Changes in orthogonal ECG in hypertensive patients taking different antihypertensive therapy

Sakhnova T., Blinova E., Ryabykina G., Shutova L., Chikhladze N., Martynyuk T., Chazova I., Sakhnova T., Blinova E., Ryabykina G., Shutova L., Chikhladze N., Martynyuk T., Chazova I.

卷 95, 编号 9 (2023)

Five-year dynamics adrenergic reactivity of erythrocytes after radio-frequency sympathic denervation of renal arteries in patients with resistant arterial hypertension

Rebrova T., Falkovskaya A., Afanasiev S., Mordovin V., Zyubanova I., Muslimova E.

(Rus)

卷 93, 编号 1 (2021)

Problems of insufficient control of target blood pressure levels in the outpatient practice

Larina V., Fedorova E., Mikhailusova M., Golovko M.

(Rus)

卷 92, 编号 9 (2020)

COVID-19 and cardiovascular diseases

Chazova I., Mironova O.

(Rus)

卷 91, 编号 12 (2019)

Evolution of pathogenetic therapy of pulmonary arterial hypertension

Chazova I., Yarovoy S., Danilov N.

(Rus)

Features of the clinical picture in patients of middle age with essential hypertension

Parfenov V., Ostroumova T., Ostroumova O., Pavleyva E.

(Rus)

卷 91, 编号 1 (2019)

Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry

Chazova I., Arkhipova O., Martynyuk T.

(Rus)

卷 95, 编号 9 (2023)

Relationship between the pain severity, use of non-steroidal anti-inflammatory drugs and blood pressure in elective large joint arthroplasty of the lower extremities

Okisheva E., Mironova O., Berdysheva M., Pyatigorets E., Krivova N., Kurnosova A., Elizarov M., Smetanin S., Lychagin A., Fomin V.

(Rus)

卷 94, 编号 9 (2022)

Ectopic obesity in patients without manifested cardiovascular disease: regulations, frequency and clinical characteristics

Podzolkov V., Bragina A., Osadchiy K., Rodionova Y., Djafarova Z., Khalenyan M., Dishkaya S.

(Rus)

Pulmonary arterial hypertension: achievements and realities of modern treatment, a look into the future

Martynyuk T., Chazova I.

(Rus)

卷 92, 编号 8 (2020)

Association of nutritional patterns and arterial hypertension in Russia: does it exist?

Lantseva M., Sasunova A., Vlasova A., Kropochev V., Pilipenko V., Morozov S., Isakov V.

(Rus)

卷 91, 编号 9 (2019)

Risk stratification methods and their significance in pulmonary arterial hypertension

Avdeev S., Tsareva N.

(Rus)

卷 90, 编号 10 (2018)

Prevalence and risk factors of sleep breathing disorders in patients with acromegaly from Moscow region

Kovaleva Y., Dreval A., Kulakov N., Fedorova S., Ilovayskaya I.

(Rus)

卷 81, 编号 4 (2009)

Quantitative repolarization indices in diagnosis of left ventricular hypertrophy in hypertensive patients

Sakhnova T., Blinova E., Sergakova L., Ataullakhanova D., Chazova I., Sakhnova T., Blinova E., Sergakova L., Ataullakhanova D., Chazova I.

卷 97, 编号 7 (2025)

Clinical portrait and features of antihypertensive therapy in comorbid patients with arterial hypertension and chronic obstructive pulmonary disease according to the national hypertension registry

Aksenova A., Serov I., Belova O., Rachkova S., Chazova I.

(Rus)

卷 93, 编号 12 (2021)

The assessment of renal function during the therapy of arterial hypertension with azilsartan medoxomil in patients with obesity or overweight and concomitant metabolic disorders

Nevzorova V., Petrichko T., Chazova I., Zhernakova J.

(Rus)

卷 93, 编号 6 (2021)

The state of cytokine regulation and endothelial dysfunction in the combined course of vibration disease and arterial hypertension

Babanov S., Baraeva R., Strizhakov L., Moiseev S., Fomin V.

(Rus)

卷 90, 编号 12 (2018)

The effectiveness of combination antihypertensive therapy in patients with arterial hypertension and additional risk factors: obesity and obstructive sleep apnea syndrome

Elfimova E., Litvin A., Chazova I.

(Rus)

(Rus)

卷 89, 编号 9 (2017)

A patient with severe idiopathic pulmonary arterial hypertension: Is there a way out?

Tsareva N., Avdeev S., Neklyudova G.

(Rus)

卷 87, 编号 9 (2015)

Approaches to therapy for pulmonary hypertension: Role of the endothelin receptor antagonist bosentan

Avdeev S.

卷 85, 编号 3 (2013)

First clinical experience with endothelin receptor antagonist bosentan used in patients with pulmonary hypertension: results of a one-year study

Avdeev S., Tsareva N., Nekliudova G., Chuchalin A.

卷 94, 编号 12 (2022)

Hyperuricemia and kidney damage in patients with cardiovascular disease: A review

Mironova O.

(Rus)

卷 93, 编号 10 (2021)

Retrospective analysis of clinical outcomes of patients with COVID-19 depending on receiving antihypertensive, lipid-lowering and antihypertensive therapy

Demidova T., Lobanova K., Perekhodov S., Antsiferov M., Oynotkinova O.

(Rus)

卷 93, 编号 4 (2021)

From palpation of the pulse to cuff-free methods: evolution of arterial pressure measurement methods

Solnceva T., Sivakova O., Chazova I.

(Rus)

Association of rs3025058 polymorphism with the development of stroke in patients with cardiovascular pathology

Nikulina S., Shulman V., Chernova A., Prokopenko S., Nikulin D., Platunova I., Tretyakova S., Semenchukov A., Marilovtseva O., Lebedeva I., Maksimov V., Gurazheva A.

(Rus)

Vitamin D deficiency and cardiovascular pathology

Podzolkov V., Pokrovskaya A., Panasenko O.

(Rus)

卷 89, 编号 8 (2017)

Bosentan use in pulmonary arterial hypertension: Russian and foreign experience

Valieva Z., Martynyuk T., Chazova I.

(Rus)

卷 80, 编号 6 (2008)

Resistent arterial hypertension

Chazova I., Fomin V.

卷 94, 编号 12 (2022)

Pharmacoepidemiological analysis of antihypertensive therapy in older age groups with senile asthenia syndrome

Davidov E., Yaskevich R.

(Rus)

卷 94, 编号 3 (2022)

Comments on the article by Professor Dmitry D. Pletnev “Hypertension (the experience of analyzing its genesis)”

Baranova I.

(Rus)

New clinical opportunities for mineralocorticoid receptor antagonists: focus on antifibrotic effects

Dragomiretskaya N., Tarzimanova A., Kucherova J., Podzolkov V.

(Rus)

卷 93, 编号 4 (2021)

Features of antihypertensive therapy and real-world prescription of selective imidazoline receptor agonists in Russia vs other countries: STRAIGHT study data analysis

Konradi A., Zvartau N., Chazova I., Zhernakova J., Schutte A., Schlaich M.

(Rus)

Detection of kidney dysfunction potential biomarkers with hypertension in the persons of 25–45 years

Kovalkova N., Khudyakova A., Kashtanova E., Polonskaya Y., Shcherbakova L., Ragino Y.

(Rus)

Arterial hypertension at the workplace: risk factors and the population value

Strizhakov L., Babanov S., Lebedeva M., Moiseev S., Fomin V.

(Rus)

卷 91, 编号 2 (2019)

Non-alcoholic fatty liver disease as a cause and consequence of cardio-metabolic complications. Role of the ursodeoxicholic acid in the pharmacotherapy

Maevskaya M., Ivashkin V., Ivashkin K., Lunkov V., Liusina E., Zozula V., Leshchenko V.

(Rus)

卷 90, 编号 2 (2018)

Comorbid for gastroduodenal ulcers in the aspect of calcium imbalance and blockers of slow calcium channels in their treatment

Fomina L.

(Rus)

Modern view on the place of riociguat in the treatment of pulmonary hypertension

Valieva Z., Taran I., Martynyuk T., Chazova I.

(Rus)

卷 88, 编号 8 (2016)

Non-drug rehabilitation of patients with chronic obstructive pulmonary disease concurrent with hypertension

Sevostyanova E., Nikolaev Y., Bogdankevich N., Lusheva V., Markova E., Dolgova N.

(Rus)

卷 80, 编号 6 (2008)

Bilateral stenosis of renal arteries in a patient with primary antiphospholipid syndrome following hemolyticouremic syndrome (a case report and review of literature)

Kozlovskaia N., Bobrova L., Zakharova E., Khafizova E., Gagarina N., Miroshnichenko N.

卷 94, 编号 12 (2022)

Subclinical markers of liver damage in patients with arterial hypertension and obesity

Sadulaeva I., Yushchuk E., Khalikova L., Krikunova O., Trofimenko O., Medvedeva E.

(Rus)

Tactics of antihypertensive therapy during COVID-19 pandemic

Podzolkov V., Bragina A., Rodionova Y., Bragina G., Bykova E.

(Rus)

卷 93, 编号 1 (2021)

Characteristics of arterial hypertension clinical course in patients with obesity and anxiety-depressive disorders

Vasyuk Y., Dovzhenko T., Dubrovskaya T., Nesterova E., Shupenina E.

(Rus)

卷 92, 编号 10 (2020)

Primary aldosteronism: The Mayo Clinic approach

Young W., Ladygina D., Balutina O., Beltsevich D.

(Rus)

卷 92, 编号 1 (2020)

Hypertension and insomnia

Ostroumova T., Parfenov V., Ostroumova O., Kochetkov A.

(Rus)

卷 91, 编号 9 (2019)

Treatment of ARVI and influenza in patients with arterial hypertension

Silina E., Sitnikov I., Fazylov V., Yeganyan G.

(Rus)

卷 91, 编号 1 (2019)

Relationships of arterial hypertension and reduced renal function in a population 25-45 years

Kovalkova N., Ragino Y., Scherbakova L., Hudyakova A., Denisova D., Voevoda M.

(Rus)